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Humans are capable of survival in a remarkable range of environments, including the extremes of temperature and
altitude as well as zero gravity. Investigation into physiological function in response to such environmental stresses
may help further our understanding of human (patho-) physiology both at a systems level and in certain disease
states, making it a highly relevant field of study. This review focuses on the application of metabolomics in
assessing acclimatisation to these states, particularly the insights this approach can provide into mitochondrial
function. It includes an overview of metabolomics and the associated analytical tools and also suggests future
avenues of research.
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Background
Human populations have successfully settled in an extra-
ordinarily diverse range of habitats, many of which
present significant environmental challenges to life in-
cluding the extremes of temperature or altitude. Recent
research has highlighted the role that natural selection is
playing in shaping the genomes of humans in such niche
environments [1-4]. However, despite significant prom-
ise, technical advances in other system-wide disciplines
such as proteomics and metabolomics have yet to yield
widespread insights into human acclimatisation and
adaptation to extreme environments. We have previ-
ously put forward the notion that systems biology and
the study of humans in extreme environments are nat-
ural symbionts [5,6]. In this review, we highlight the ap-
plication of metabolomics in such studies, with three
specific aims:
1. To serve as a broad introduction to the field of
metabolomics for the non-expert, with the aim of
promoting its more widespread use in the field.* Correspondence: lindsay.m.edwards@gsk.com
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unless otherwise stated.2. To illustrate how metabolomics can provide insight
into the role of mitochondria in acclimatisation to
extreme environments.
3. To suggest potentially fruitful avenues for future
research, deploying metabolomics methods in
human extreme environmental research.
Broadly, the review will follow these points in order,
starting with an overview of the methods of metabolomics.A brief introduction to metabolomics
In recent years, technological advances have allowed for the
unbiased detection, identification and semi-quantification
of many low molecular weight (<1,500 Da) compounds in
cells, tissues, biofluids or organisms, in a single experiment.
Metabolites are the reactants, intermediates or products of
enzymatic reactions in the body. They represent the final
products of cellular processes including the activity of
mRNA and proteins and are key components of mitochon-
drial processes such as the tricarboxylic acid (TCA) cycle
and β-oxidation. Investigation into the metabolic pheno-
type, or metabolome, in response to a physiological stimu-
lus or genetic modification, termed metabolomics, is a
functional level of systems biology [7]. Unlike changes in
the proteome or transcriptome, which are usually measured
over minutes to hours, the metabolome is highly dynamic
and subject to fluxes over a period of seconds or less. The
metabolome is therefore an extremely sensitive measure of. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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phenotypic changes that have no frank physiological or
characteristic behaviours [8,9], particularly when used with
other -omic approaches [10-12].
Analytical tools
The human metabolome is estimated to comprise of
many tens of thousands of individual metabolites, in-
cluding both those confirmed and predicted, endogen-
ous and xenobiotic [13-15]. The human metabolome
database (available at www.hmdb.ca), for instance, con-
tains 41,992 metabolite entries.
The atomic arrangement of metabolites is highly di-
verse. Chemical properties vary enormously, ranging
hydrophilic, polar metabolites with a low molecular
weight (e.g. amino acids) to hydrophobic, non-polar
higher molecular weight metabolites (e.g. lipids) [8]. This
sets metabolome analysis apart from that of the tran-
scriptome or proteome as information within DNA,
RNA or peptides is encoded in patterns constructed
from uniform constituent chemical subunits (i.e. poly-
merised nucleic acids and amino acids). Moreover, me-
tabolite concentrations also vary from the mmol/l to
pmol/l range.
This extreme diversity makes unbiased detection (as is
possible in transcriptomics) exceptionally challenging.
Indeed, detection and quantification of all metabolites in
human samples cannot currently be achieved using a
singular analytical technique. Furthermore, there are
few good methods for amplification of metabolite levels
as there exists for genomics and transcriptomics in the
various forms of the polymerase chain reaction. How-
ever, nuclear magnetic resonance (NMR) spectroscopy
and mass spectrometry (MS) coupled with chromatog-
raphy are both popular and increasingly used analytical
approaches [13]. The resulting signals are identified
using data libraries, such as the human metabolome
database [16], or experimentally using analytical chem-
istry techniques for structure elucidation and with me-
tabolite standards where available.
Nuclear magnetic resonance spectroscopy
NMR experiments are performed on atomic nuclei with
a non-zero spin quantum number (a quantum property
of the nucleus related to angular momentum and charge
and often symbolised as a spinning magnetic field), such
as 1H, 13C or 31P. All of the aforementioned nuclei pos-
sess a spin angular momentum quantum number ½ and
can exist in two energy levels—often referred to as spin
up or spin down.
In a large population of identical nuclei at equilibrium,
the spin and related magnetic moments of individual nu-
clei have equal energy (i.e. they are degenerate), and
both are randomly arranged. In an NMR experiment,nuclei are exposed to a powerful magnetic field which
creates a population difference between the spin up and
down nuclei as there is a slight excess of the lower en-
ergy state (this is often the spin down state). The energy
difference is relatively small, comparable to the thermal
energy in the system, and irradiation with a pulse of ra-
diofrequency wave of the right frequency will convert
spins of the lower energy state to the higher one until
the population difference is cancelled out. The irradiat-
ing radiofrequency waves are then turned off, allowing
the nuclei to relax back to their equilibrium potential
over a period of time by emitting a characteristic radio-
frequency signal. This is called a free induction decay,
and if the signal is transferred from time to frequency
using a mathematical approach called a Fourier trans-
form, then a spectrum arises. The area of the resonance
is directly proportional to the concentration of nuclei
that generate it, making NMR innately quantitative. As
described, this would be a poor analytical technique,
only able to separate out nuclei of different atoms, but
the chemical environment each nucleus is found within
modulates the frequency. Thus, the spectrum produced
by a metabolite will encode information about the
structure making it a powerful analytical approach.
Another important advantage is that the sample itself
has only been exposed to a magnetic field and radiofre-
quency pulse, making NMR completely non-destructive
enabling re-use of samples and avoiding the instru-
ment being impaired by the accumulation of unwanted
analyte [17].
As described above, the properties of the chemical en-
vironment surrounding the nuclei cause a shift in the
resulting resonances. This is caused by a number of fac-
tors, including the shielding effects of the electron cloud
surrounding the nucleus that alters the local field at the
nucleus. The 1H nuclei resonances will reflect the chem-
ical group to which that particular nucleus belongs. Vari-
ation in this NMR frequency, or ‘chemical shift’, is small
(most 1H frequencies only vary within a range of 10 parts
per million) but can be measured with great accuracy en-
abling a detailed identification of compounds [17,18].
Chemical shift is also affected by the properties of sur-
rounding nuclei. The energies of nuclei positioned close
together interact, a phenomenon denoted spin-spin coup-
ling, which causes the chemical shift to be split into sub-
peaks. Distinct molecules have a characteristic number
and pattern of peaks and sub-peaks [18], and this can be
used to great effect in two- and multi-dimensional NMR
spectroscopy [19].
Analysis of NMR spectra gives precise information re-
garding chemical structure and abundance of the mole-
cules of which the nuclei form a part, thus enabling
metabolite identification [17,18]. The quantitative na-
ture, high reproducibility and relatively simple sample
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is also non-selective, as the sensitivity is independent of
the hydrophobicity or acidity of the compounds being
analysed [8]. One large downside to the approach is its
relatively poor sensitivity, which arises because the nu-
clear transitions that are measured in the NMR experi-
ment are very close to the thermal energy of the system,
meaning population differences between the low and
high energy states are very small [8]. Only those metabo-
lites in high abundance (100 nmol/l to 1 μlmol/l or
higher) can be detected, with usually less than 100 me-
tabolites detectable per sample in a typical liquid-state
metabolomics experiment [18,20]. Further, 1D spectros-
copy (typically used for metabolomics experiments) re-
sults in spectral crowding: alterations in low-abundance
metabolites may be obscured by those species in higher
abundance and with similar chemical shifts, which in
turn limits biomarker discovery. Although 2D NMR
spectroscopy offers a solution to this problem, it also
results in increased instrument time and, therefore,
cost. However, this is beginning to be addressed
through developments in cryoprobes to improve sensi-
tivity and sparse sampling to speed up 2D acquisitions
[21-23].
NMR experiments are typically performed on samples
in the liquid state. This includes biofluids, such as
plasma, serum or urine, and also metabolites extracted
from tissue that are re-dissolved in solvent. This is be-
cause in the liquid state, metabolites tumble readily.
The action of tumbling ensures that a narrow NMR res-
onance is obtained which simplifies the resultant spec-
tra. The spectra produced from NMR analysis of tissue
extracts are generally well resolved, and valuable infor-
mation can be gained from this. However, as the integ-
rity of the tissue is destroyed during the extraction
process, this is not necessarily a good representation of
in vivo function. Another option is to use untreated
intact tissue in the solid state. High-quality, well-
resolved NMR data can be achieved from this matrix
using high-resolution magic angle spinning (HR-MAS).
The ‘magic angle’, 54.7° relative to the applied magnetic
field, reduces NMR peak widths, attenuating the line-
broadening effects produced in solid samples and so im-
proving spectral quality to near-liquid state [24,25]. The
information acquired from HR-MAS is therefore more
comparable to in vivo function. It also enables the study
of time-dependent metabolic processes to be assessed in
a tissue [26].
Finally, in vivo NMR analysis of tissue biochemistry can
be conducted using a surface radiofrequency coil, which
allows for the detection of compounds in localised
regions adjacent to the coil (and hence the sample sur-
face) [27]. In techniques such as 31-phosphorus mag-
netic resonance spectroscopy (31P-NMR), this enablesdetection of tissue phosphorus metabolites and phos-
phocreatine and so provides insight into tissue ener-
getics [28].
Mass spectrometry
The other major technique currently applied in metabo-
lomic analysis is MS. This operates by the formation of
positively or negatively charged species (ions) from ana-
lytes of interest (in this case metabolites), which are then
separated according to their mass-to-charge ratio.
MS is performed either with or without a precedent
separation step. While gas chromatography-MS (GC-
MS) was the dominant MS platform for some years, im-
provements in technologies have led to the widespread
adoption of liquid chromatography-MS (LC-MS) as the
analytical tool of choice for MS metabolomics. This in-
cludes technologies that enhance sensitivity and separ-
ation resolution, such as ultra-performance liquid
chromatography [8]. However, there are many applica-
tions where GC-MS is still very popular (e.g. analysis of
total fatty acids, analysis of core metabolism in plants).
The high sensitivity afforded by LC-MS has greatly
aided in the development of metabolomics, enabling de-
tection of hundreds or even thousands of metabolites in
a given sample [29]. This includes detection of metabo-
lites at very low abundance (1 pmol/l) [8]. In spite of
this, metabolite identification remains a significant
hurdle.
Chromatography
Chromatographic separation of the molecular species
within a sample is usually used prior to infusion into
the mass spectrometer. This simplifies the resultant
mass spectra collected and also improves the ionisation
of individual analytes. The most commonly used tech-
niques are liquid or gas chromatography (LC and GC,
respectively).
In LC, the analyte mixture is dissolved into a liquid
mobile solvent (the mobile phase), which is then passed
through a column containing surfaces coated with spe-
cific interaction chemistries (the stationary phase). The
speed at which individual analytes pass through the col-
umn is dependent upon their physiochemical inter-
action with the stationary phase. As analytes are
separated in the liquid phase, this makes it suitable for
analysis of both polar and lipophilic thermally labile
compounds in the solution. The reduction in pre-
processing in comparison to GC (described below) ex-
plains one of the reasons for its increased popularity.
Different LC column chemistries enable efficient separ-
ation of metabolites with varying properties. Non-polar
columns with carbon chain chemistries, such as the
near-ubiquitous C18 column, enable efficient separation
of lipid species, whereas the polar chemistries found
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umns (HILIC) enable separation of more polar com-
pounds [8,20].
By contrast, in GC, analytes are vaporised and so the
mobile phase is gaseous. The analyte species therefore
need to be non-polar volatiles, meaning a volatile deriva-
tisation step is usually required. For instance, fatty acids
are derivatised to form fatty acid methyl esters and polar
head groups are often reacted with trimethylsilyl deriva-
tives. In GC, the temperature of the column is increased
in an oven, allowing a partition of metabolites between
the stationary and mobile phases at different tempera-
tures. Thus, a chromatogram is produced according to a
temperature gradient.
Ionisation
Components eluting from the chromatographic column
are introduced to the mass spectrometer via a special
ionisation interface. The ionisation technique adopted is
dependent upon the prior chromatography step. Elec-
tron ionisation is used almost exclusively with GC as it
requires volatile analytes. It is a very reproducible form of
ionisation, and this has aided the production of GC-MS
libraries of metabolites. It produces inherent molecu-
lar fragmentation, which can be applied for metabolite
identification.
Electrospray ionisation on the other hand ionises non-
volatiles, making it suited for use with LC and is optimal
for the separation of complex biological fluids [30].
Here, ions are formed in solution within the needle be-
fore droplet formation from the Taylor cone. Subsequent
measurement of metabolite species is dependent upon
the ionisation mode. In negative ionisation mode, there
is preference for detection of anionic species such as or-
ganic acids, whereas in positive ionisation mode, there is
preference for detection of neutral (which often pick up
a H+ or other suitable cation during the process to form
an adduct) and cationic metabolites including proton-
ated amino acids and amines.
A downside of this essential step is the possibility of
ion suppression, which occurs in complex biological mo-
lecular mixtures when analytes compete for charge dur-
ing the ionisation process [31]. The detected ‘abundance’
signal of a compound can be affected by other sub-
stances including analytes and contaminants. Although
the initial chromatographic separation helps to reduce
suppression effects by simultaneously reducing the num-
ber of species entering the ionisation step, the problem
can still persist [32].
Mass analysis
The fundamental principle of MS is that ions, including
molecular, fragment and adducts, are separated accord-
ing to their mass-to-charge ratio (m/z). In metabolomicsexperiments, the vast majority of ions carry a single
charge (i.e. z = 1), meaning that m/z usually =m.
Although it is possible to resolve many thousands of
signals in a single MS experiment, the unambiguous
identification of unique metabolites presents the most
significant current analytical and experimental challenge
for investigators [33]. Positive identification of a metab-
olite requires several parameters, including accurate
mass, fragmentation pattern, isotope abundance pattern
and retention time, to match with that of a purified
metabolite under identical conditions. This definitive
identification is not plausible for large numbers of me-
tabolites. It is therefore broadly accepted for metabolites
to be ‘putatively annotated’, a term defined by the Meta-
bolomics Standards Initiative [34]. This method of iden-
tification uses a single measured parameter, such as
accurate mass, and matches this to a metabolite present
in a library or database. Although less time-consuming
than definitive identification, the confidence in correct
identification is lower [35], hence ‘key’ compounds still
need to be annotated more rigorously. Indeed, some
claim that unless metabolites are identified by two or-
thogonal techniques the assignment should still be la-
belled as tentative [34].
It is also worthy of note that structural similarities
within lipid classes (e.g. the eight broad classes outlined
in the LIPID MAPS classification system [36]) allow the
measurement and (at least partial) classification of a
large number of lipid species in a single MS run. How-
ever, the increased structural complexity and size of
many lipids, including differing isomers and fatty acid
constituents, makes completely unambiguous identifica-
tion challenging.
Targeted and non-targeted metabolomics
Metabolomics can either be targeted or non-targeted.
Both have their advantages and disadvantages and can
be highly effective and complementary when used in
conjunction.
Untargeted metabolomics attempts to measure all the
analytes in a sample, including chemical unknowns. In
this approach, there is no specific a priori hypothesis
stating which metabolites are related to the (patho-)
physiological change. It aims to produce data on an ex-
tensive range of metabolites present in multiple metab-
olite classes or pathways that are dispersed across the
metabolic network. The metabolome coverage is there-
fore intended to be unbiased and as comprehensive as
possible. This method is not quantitative, and metabolite
identification is a challenge. In order to reduce the
resulting data sets into more manageable entities, dimen-
sion reduction techniques such as principal components
analysis (PCA) or multidimensional scalings are required.
The results of such experiments can be inductive or
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changes occurring to the metabolome as a result of the
perturbed state [8,37].
Targeted metabolomics involves the detection of a spe-
cific number of metabolites (typically in the order of tens
to hundreds) that are related in function or class. This
method is used in hypothesis testing or deduction stud-
ies where the metabolites (or at least, pathways) of inter-
est are known.
A major development effort is required to establish a
successful targeted technique. Absolute quantitative me-
tabolite concentrations are determined with high specifi-
city and accuracy by using the addition of internal
standards. These are typically isotopically labelled ver-
sions of the endogenous metabolites, usually containing
13C or 2H isotopes [8]. As only those targeted metabo-
lites are detected, this does mean that the number of
discovery opportunities is reduced. However, one hybrid
option is to use semi-quantitative methods where a
number of ‘class-specific’ standards are spiked into sam-
ples. This relies on the assumption that similar classes of
compounds give comparable signals.
Metabolomics and extreme environments
The metabolomics approach aims to measure metabo-
lites at baseline or in the context of a perturbed state.
Yet there are a limited number of ethical physiological
perturbations that can be used in experiments on
humans; these include exercise, nutrition, some drugs
and the environment. It has been argued that environ-
mental physiology can provide insight into the system-
level understanding of the human body [5] and into a
number of pathological states.
Studying the healthy human response to extreme envi-
ronments has been used widely to investigate fundamen-
tal physiology (perhaps with pathological importance)
without the confounding factors and complications
prevalent in a diseased population [38]. This is particu-
larly relevant for investigations into high-altitude physi-
ology. Inadequate availability of oxygen to the tissues
(hypoxia) as occurs at high altitudes is also a feature of a
plethora of clinically important conditions. These in-
clude lung disease, heart failure, anaemia, cancer and
regional vascular diseases [39-43]; indeed, any clinical
condition where either convective or diffusive oxygen
transport is impaired.
Metabolomics and altitude
Hypoxia at high altitudes results from a reduction in in-
spired partial pressure of oxygen. Acclimatisation is
partly dependent upon changes to oxygen-dependent
processes, including mitochondrial oxidative phosphor-
ylation. Oxidative means of energy production are essen-
tial for normal physiological function as few cells areable to rely solely upon anaerobic means of energy gen-
eration [44]. Severe hypoxia can lead to such a decline
in bodily functions that it may rapidly become fatal [45].
Survival in the face of reduced oxygen availability thus
requires a profound shift in metabolic processes.
The few extant metabolomics experiments inves-
tigating the physiology of high altitude have focused
on profiling plasma, serum or urine from hypoxia-
exposed individuals. Tissot van Patot and colleagues
[46] performed metabolomic profiling on samples
taken from subjects following 8-h exposure to 12%
oxygen (equivalent to ~4,300 m) in a hypobaric chamber.
Assessment of plasma using 1H-NMR revealed an increase
in L-lactic acid (HMDB00190) and succinic acid
(HMDB00254) concentrations, by 29% and 158%, respect-
ively, in response to hypoxia [46]. These findings are in
line with previous studies suggesting that hypoxia
prompts a shift towards anaerobic means of energy gen-
eration through an active shunting of pyruvate away
from entry into the TCA cycle towards lactate produc-
tion and an inhibition of TCA cycle activity [47-49]. Ac-
cumulation of succinate may be indicative of a
concerted downregulation of TCA cycle and electron
transport chain (ETC.) activity, given that succinate de-
hydrogenase is also complex II of the ETC. Interestingly,
succinate is also suggested to have a toxic effect in the
heart in response to ischemia, as its accumulation has
been directly linked to mitochondrial reactive oxygen
species production from complex 1 [50]. Plasma ana-
lysis by Tissot van Patot and colleagues also revealed a
reduction in the levels of the antioxidant glutathione.
This was coupled with an increase in urinary prostane
excretion, as assessed using LC-MS [46]. This supports
the concept that oxidative stress increases in response
to hypoxia [51,52].
It is not clear whether these apparent adjustments in
metabolic processes during hypoxia translate to an al-
tered exercise economy at a whole body level. When
considering the energetics of the skeletal muscle at alti-
tude, it seems that exercising metabolites are unaltered
in subjects trekking to 5,300 m and climbers ascending
above 7,950 m. By the use of 31P-NMR, the half-life of
phosphocreatine (PCr) (a widely accepted measure of
mitochondrial function) was found to remain at sea
level values, indicating that skeletal muscle mitochon-
drial function was maintained. This occurred despite a
reduction in muscle cross-sectional area and aerobic
capacity. Thus, the metabolic changes occurring in
healthy humans at high altitude preserve in vivo func-
tion in the face of profound structural changes [28] in a
manner that remains poorly understood. In the human
heart, however, the ratio of PCr/adenosine triphosphate
(ATP) becomes impaired [53,54], perhaps suggesting
that in the heart, which has a greater mitochondrial
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dative phosphorylation is not preserved.
It appears that, given adequate acclimatisation time,
healthy humans are capable of achieving successful
metabolic acclimatisation to ameliorate oxidative stress.
Placenta extracts analysed after labour birth from
subjects either at altitude (3,100 m) or sea level using
1H-NMR and 31P-NMR spectroscopic analysis [55] sug-
gested that those placentas which had developed at alti-
tude had adapted to hypoxia, demonstrating a blunted
oxidative stress response during labour and a precondi-
tioning to energy storage through higher PCr concentra-
tions [55].
High-altitude pulmonary oedema
If ascent to high altitudes is rapid with insufficient time
allowed for acclimatisation, this can lead to the onset of
life-threatening pathologies such as high-altitude pul-
monary oedema (HAPE). The pathogenesis of HAPE re-
mains unknown, and early diagnosis or prognostic
prediction is essential for preventing morbidity, yet isFigure 1 A summary of current knowledge on the stresses experienced by
insights into mitochondrial acclimatisation provided by existing metabolomnot straightforward [56,57]. Metabolic analysis of plasma
taken from 10 subjects at 3,658 m with HAPE revealed sig-
nificant changes in 11 metabolites compared with healthy
controls exposed to the same altitude; these include glycine
(HMDB00123), citric acid (HMDB00094) and creatinine
(HMDB00562) [58]. This study highlights the potential
for the use of metabolomics as a diagnostic technique
through the determination of disease biomarkers, al-
though (as with many metabolomic biomarkers) these
are likely to suffer from a lack of specificity. This has
already been recognised for cardiovascular disease, and
the current available biomarkers have the same limita-
tions for screening purposes [37].Metabolomics and the response to heat and cold
Many human populations live in extreme heat or cold.
Both of these environmental stresses can cause exacer-
bation of disease and are potentially lethal [59,60]. The
metabolic responses to neither extreme heat nor cold
have been well investigated.mitochondria in response to extreme environment exposure with
ics studies and suggested avenues of future metabolomics research.
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in metabolic processes and initiate heat-dissipating pro-
cesses such as sweating. Although, to our knowledge, no
metabolomics studies have been conducted in humans,
the subject has been explored in a limited way in insects
and rats. Results from these studies indicate shifts in TCA
cycle functioning and an increased reliance on glycolysis
during heat stress [61-63]. Inter-species differences obvi-
ously limit the translation of these results to humans, and
work is required to further our understanding of the
metabolome-wide response to heat stress in humans.
Acclimatisation to extreme cold undoubtedly relies
heavily on behavioural adaptations such as the wearing
of warm clothing and, in the short-term, shivering. How-
ever, with acclimatisation, there is also a heavy reliance
on metabolic processes for non-shivering thermogenesis.
Of particular interest are those changes taking place in
mitochondria located within adipose tissue. Uncoupling
of oxidative phosphorylation here is thought to play an
essential role in cold-induced thermogenesis, a response
believed to be regulated by the cold-sensing receptor
TRPM8 expressed in both white and brown adipose tis-
sue [64,65].
A strong correlation between basal metabolic rate
(BMR) and climate has also been observed [66]. The
BMR of indigenous Siberian populations, for example,
was found to be 5% higher than values predicted based
on body mass. These elevations appeared to be attribut-
able to environmental stress rather than high dietary
protein consumption, as was previously believed [67].
The reliance on metabolic processes for enabling sur-
vival in the extremes of heat and cold imply that the
metabolic profile would undergo significant changes and
so warrants further investigation.Metabolomics and human spaceflight
A growing number of humans have experienced perhaps
the most extreme of environments through spaceflight,
and our understanding of the physiological response to an
extended exposure to microgravity is similarly growing
[68]. With commercial spaceflight, a realistic prospect for
the next decade, this experience will be offered for the first
time to individuals outside a highly trained elite corps of
astronauts. It has been proposed that -omics methodolo-
gies, including metabolomics, form the cornerstone of a
personalised medicine regime for the identification and
treatment of microgravity-related conditions [69]. The
application of metabolomics to head-down-tilt bedrest
studies (as employed by NASA and ESA as a human
spaceflight analogue) would be revealing in this regard,
not least because of the documented effects of standard
bedrest on exercise capacity, muscle wasting and insulin
resistance, even in healthy young men [70].Conclusions
It is clear that metabolomic studies of the human re-
sponses to altered climate and environment are worth-
while and lacking (summarised in Figure 1). Such
studies could greatly further our understanding of
human physiology and molecular biology. This work
has the potential also to further our understanding of
diseases that result from, or are akin to, physiology in
extreme environments. It is clear that large-scale, longi-
tudinal studies are required as studies conducted over
longer periods of time would be better suited to provid-
ing information specific to these states. A combined use
of targeted and untargeted approaches could also be
employed to enable optimal detection.
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